Randomized Controlled Trial of Metacognitive Training: a Clinical Psychological Investigatio
Not Applicable
- Conditions
- schizophrenia
- Registration Number
- JPRN-UMIN000027301
- Lead Sponsor
- the University of Tokyo, Graduate School of Arts and Sciences
- Brief Summary
The primary outcome was positive symptom score, as measured by PANSS. GAF and measures of cognitive biases were secondary outcomes. The severity of PANSS positive symptoms declined significantly in the TAU+MCT treatment group compared with the TAU group. GAF also showed significantly greater improvement in the TAU+MCT group compared with the TAU group. There was also a trend for greater efficacy of MCT on cognitive biases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
people (1)with intellectual disorder, developmental disorder, organic brain dysfunction and substance abuse (2)score above 5 in "hostility", or above 6 "suspicion" of PANSS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The scores of positive symptoms in PANSS (1)Pre MCT (2)Five weeks after the beginning of MCT (3)Post MCT (4)Four weeks follow-up
- Secondary Outcome Measures
Name Time Method Global Assessment of Functioning(GAF), Cognitive Bias Questionnaire for psychosis(CBQp), Beck Cognitive Insight Scale(BCIS), Self-Efficacy for Community Life Scale of Schizophrenia(SECL), Maladaptive and Adaptive Coping Styles Questionnaire(MAX), EQ-5D-5L, Beck Depression Inventory 2(BDI-2), Rosenberg Self-esteem Scale(RSES) (1)Pre MCT (2)Five weeks after the beginning of MCT (3)Post MCT (4)Four weeks follow-up